Trends in pancreatic cancer related mortality; a retrospective analysis using CDC WONDER Database
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Pancreatic cancer is 8th most prevalent cancer in the United States with a very high mortality rate. Understanding the epidemiology of Pancreatic cancer is important in identifying the causes and developing preventive strategies. Methodology: Data from the death certificates spanning from 1999–2020, sourced from CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) was analyzed. To quantify national annual trends in pancreatic cancer-related mortality, the Joinpoint Regression Program was used to determine the annual percent change (APC) with 95% CI in age-adjusted mortality rates (AAMRs) per 100,000 people for all ages stratified by year, gender and regions. Results Pancreatic neoplasm claimed about 847,589 lives across all age groups in the US from 1999–2000. The AAMR for pancreatic cancer peaked at 2020 with 11.7 [APC 0.2275 95% CI: 11.6–11.8]. The AAMR for pancreatic cancer-related deaths was 11(95%CI: 10.9 = 11.1) in 2003 and it increased to 11.3(95%CI: 11.2–11.3) in 2006 (APC 0.87* 95%CI: 11.2–11.4). Men had consistently higher AAMRs than women across all age groups throughout the study period of 1999–2000 (overall AAMR men: 13.2 (95% CI: 13.1–13.2); overall AAMR women: 9.9 (95% CI: 9.9–10)). Geographically; the lowest mortality was displayed by the Western regions (AAMR 10.5, 95% CI: 10.2–10.7), followed by Southern (AAMR 11.1, 95%CI: 10.9–11.4), followed by Midwestern (AAMR 11.7, 95%CI: 10.9–11.4), followed by Northeast region (AAMR 11.9, 95%CI: 11.6–12.1) Conclusion We observed an overall annual increase in mortality trends related to pancreatic cancer especially in men and certain regions like Northeast region of the United States. These results emphasize the immediate necessity for a comprehensive strategy to address this lethal illness, encompassing breakthroughs in medical research, focused public health initiatives, and extensive governmental reforms.
